Literature DB >> 17489760

Tumor suppresser gene p53 expression in premalignant lesions and gastric carcinoma - prognostic value.

Zora Vukobrat-Bijedić1, Svjetlana Radović, Azra Husić-Selimović, Srdan Gornjaković.   

Abstract

The aim of the study was to verify the presence of mutated tumor suppresser gene p53 in intestinal mucosa with histologically confirmed premalignant lesions and gastric carcinoma, and assess its prognostic value. The paper presents prospective study that included 50 patients with gastric adeno-carcinoma of intestinal type that were treated at Gastroenterohepatology Clinic, and 50 patients with histologically confirmed chronic atrophic H. pylori positive gastritis. In the mucosa biopsy samples, we analyzed presence, frequency and severity of inflammatory-regenerative, metaplastic and dysplastic changes. We typed intestinal metaplasia immunohistochemically and confirmed the presence of p53 onco-protein in antigen positive gastric carcinoma cells, and evaluated its prognostic value. Our results suggest that H. pylori acts as an initiator of inflammatory processes in gastric mucosa, which are followed by emergence of precancerous lesions. p53 is expressed late in carcinogenesis (14%) and as such, may be considered as an indicator of transformation of premalignant into malignant lesion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17489760      PMCID: PMC5802291          DOI: 10.17305/bjbms.2007.3080

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  15 in total

Review 1.  Gastric epithelial dysplasia.

Authors:  G Y Lauwers; R H Riddell
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

2.  Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development.

Authors:  I Sasaki; T Yao; H Nawata; M Tsuneyoshi
Journal:  Cancer       Date:  1999-04-15       Impact factor: 6.860

3.  Loss of E-cadherin expression in early gastric cancer.

Authors:  P Blok; M E Craanen; W Dekker; G N Tytgat
Journal:  Histopathology       Date:  1999-05       Impact factor: 5.087

4.  Diet, Helicobacter pylori, and p53 mutations in gastric cancer: a molecular epidemiology study in Italy.

Authors:  D Palli; N E Caporaso; Y H Shiao; C Saieva; A Amorosi; G Masala; J M Rice; J F Fraumeni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-12       Impact factor: 4.254

Review 5.  Atrophy, metaplasia and dysplasia: are they reversible?

Authors:  R M Genta
Journal:  Ital J Gastroenterol Hepatol       Date:  1998-10

6.  Infrequent loss of heterozygosity of APC/MCC and DCC genes in gastric cancer showing DNA microsatellite instability.

Authors:  D C Fang; J R Jass; D X Wang; X D Zhou; Y H Luo; J Young
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

7.  Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma.

Authors:  R J Cahill; C Kilgallen; S Beattie; H Hamilton; C O'Morain
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

8.  Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer.

Authors:  D C Fang; J R Jass; D X Wang
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

Review 9.  Helicobacter pylori and gastric carcinogenesis.

Authors:  P Correa
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

10.  Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer.

Authors:  M S Wu; C T Shun; W C Lee; C J Chen; H P Wang; W J Lee; J C Sheu; J T Lin
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.